GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bright Green Corp (OTCPK:BGXX) » Definitions » ROCE %

BGXX (Bright Green) ROCE % : -57.67% (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Bright Green ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Bright Green's annualized ROCE % for the quarter that ended in Jun. 2024 was -57.67%.


Bright Green ROCE % Historical Data

The historical data trend for Bright Green's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bright Green ROCE % Chart

Bright Green Annual Data
Trend Dec20 Dec21 Dec22 Dec23
ROCE %
-38.79 -30.71 -228.78 -67.27

Bright Green Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -74.44 -44.61 -44.24 -66.93 -57.67

Bright Green ROCE % Calculation

Bright Green's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=-8.891/( ( (22.788 - 7.523) + (17.403 - 6.236) )/ 2 )
=-8.891/( (15.265+11.167)/ 2 )
=-8.891/13.216
=-67.27 %

Bright Green's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jun. 2024 )  (Q: Mar. 2024 )(Q: Jun. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jun. 2024 )  (Q: Mar. 2024 )(Q: Jun. 2024 )
=-6.096/( ( (15.956 - 4.677) + (15.981 - 6.119) )/ 2 )
=-6.096/( ( 11.279 + 9.862 )/ 2 )
=-6.096/10.5705
=-57.67 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bright Green  (OTCPK:BGXX) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Bright Green ROCE % Related Terms

Thank you for viewing the detailed overview of Bright Green's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bright Green Business Description

Traded in Other Exchanges
N/A
Address
1033 George Hanosh Boulevard, Grants, NM, USA, 87020
Bright Green Corp is a provider of cannabis, cannabis-related products, and other legal medicinal plant-based therapies, manufactured for research and pharmaceutical applications, as well as being an active ingredient in consumer-based solutions. The company plans to focus on the development of cannabis strains and sales of products with high contents of CBN (cannabinol) and CBG (cannabigerol).
Executives
Saleem Elmasri officer: Chief Financial Officer 450 PARK AVE SOUTH, 3RD FLOOR, NEW YORK NY 10016
Lynn Stockwell director, 10 percent owner 401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Gurvinder Singh officer: Chief Executive Officer 1033 GEORGE HANOSH BOULEVARD, GRANTS NM 87020
Seamus Mcauley officer: Chief Executive Officer 1033 GEORGE HANOSH BOULEVARD, GRANTS NM 87020
Edward A. Robinson director, officer: Chief Executive Officer 401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Alfie Morgan director 401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Dean Vallore director 401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Terry Rafih director, 10 percent owner 401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Robert Arnone director 401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
E. Mailloux Enterprises, Inc. 10 percent owner 3129 MARENTETTE AVENUE, UNIT 2, WINDSOR A6 N8X 4G1